Literature DB >> 25097110

How does preeclampsia predispose to future cardiovascular disease?

Dawn C Scantlebury1, Sharonne N Hayes.   

Abstract

Over the last few decades, there has been increasing emphasis on cardiovascular disease in women and study of female-specific cardiovascular risk factors. Hypertension in pregnancy, and specifically preeclampsia, has been identified as one such risk factor. In this review, we explore the epidemiological evidence for preeclampsia as a risk factor for cardiovascular disease. We propose reasons for this association, giving evidence for potential pathways linking preeclampsia with future cardiovascular disease.

Entities:  

Mesh：

Year:  2014        PMID： 25097110     DOI： 10.1007/s11906-014-0472-6

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


  67 in total

1.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

2.  Maternal cardiac dysfunction and remodeling in women with preeclampsia at term.

Authors:  Karen Melchiorre; George Ross Sutherland; Aigul Baltabaeva; Marco Liberati; Basky Thilaganathan
Journal:  Hypertension       Date:  2010-11-22       Impact factor: 10.190

3.  Left atrial mechanical functions in pre-eclampsia.

Authors:  Metin Ingec; Mustafa Yilmaz; Fuat Gundogdu
Journal:  J Obstet Gynaecol Res       Date:  2005-12       Impact factor: 1.730

4.  Increased cardiovascular risk after pre-eclampsia in women with dysglycaemia.

Authors:  S D McDonald; S Yusuf; M W Walsh; E Lonn; K Teo; S S Anand; J Pogue; S Islam; P J Devereaux; H C Gerstein
Journal:  Diabet Med       Date:  2013-01       Impact factor: 4.359

5.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

Review 6.  Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension.

Authors:  Florian Herse; Babbette LaMarca
Journal:  Am J Reprod Immunol       Date:  2012-12-28       Impact factor: 3.886

7.  Preeclampsia is associated with persistent postpartum cardiovascular impairment.

Authors:  Karen Melchiorre; George Ross Sutherland; Marco Liberati; Basky Thilaganathan
Journal:  Hypertension       Date:  2011-08-15       Impact factor: 10.190

8.  Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk.

Authors:  Yoav Yinon; John C P Kingdom; Ayodele Odutayo; Rahim Moineddin; Sascha Drewlo; Vesta Lai; David Z I Cherney; Michelle A Hladunewich
Journal:  Circulation       Date:  2010-10-18       Impact factor: 29.690

9.  A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies.

Authors:  J W Meekins; R Pijnenborg; M Hanssens; I R McFadyen; A van Asshe
Journal:  Br J Obstet Gynaecol       Date:  1994-08

Review 10.  Advances in the pathophysiology of pre-eclampsia and related podocyte injury.

Authors:  Iasmina M Craici; Steven J Wagner; Tracey L Weissgerber; Joseph P Grande; Vesna D Garovic
Journal:  Kidney Int       Date:  2014-02-26       Impact factor: 10.612
View more
  6 in total

Review 1.  A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy.

Authors:  Giorgina Barbara Piccoli; Gianfranca Cabiddu; Santina Castellino; Giuseppe Gernone; Domenico Santoro; Gabriella Moroni; Donatella Spotti; Franca Giacchino; Rossella Attini; Monica Limardo; Stefania Maxia; Antioco Fois; Linda Gammaro; Tullia Todros
Journal:  J Nephrol       Date:  2017-04-22       Impact factor: 3.902

2.  Maternal serum uric acid concentration is associated with the expression of tumour necrosis factor-α and intercellular adhesion molecule-1 in patients with preeclampsia.

Authors:  J Zhao; D-Y Zheng; J-M Yang; M Wang; X-T Zhang; L Sun; X-G Yun
Journal:  J Hum Hypertens       Date:  2015-10-29       Impact factor: 3.012

Review 3.  Preeclampsia beyond pregnancy: long-term consequences for mother and child.

Authors:  Hannah R Turbeville; Jennifer M Sasser
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-06

4.  Sildenafil Citrate Does Not Reprogram Risk of Hypertension and Chronic Kidney Disease in Offspring of Preeclamptic Pregnancies in the Dahl SS/Jr Rat.

Authors:  Hannah R Turbeville; Ashley C Johnson; Michael R Garrett; Jennifer M Sasser
Journal:  Kidney360       Date:  2020-04-17

Review 5.  What a paediatric nephrologist should know about preeclampsia and why it matters.

Authors:  Giorgina Barbara Piccoli; Massimo Torreggiani; Romain Crochette; Gianfranca Cabiddu; Bianca Masturzo; Rossella Attini; Elisabetta Versino
Journal:  Pediatr Nephrol       Date:  2021-11-04       Impact factor: 3.651

6.  Apolipoprotein A1 mimetic peptide ATI-5261 reverses arterial stiffness at late pregnancy and early postpartum in a COMT-/- mouse model of preeclampsia.

Authors:  Shutan Liao; Hao Wu; Ruiying Chen
Journal:  Clin Hypertens       Date:  2018-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.